Alaunos Therapeutics Inc (TCRT)
1.38
+0.06
(+4.55%)
USD |
NASDAQ |
May 07, 09:59
Alaunos Therapeutics Total Liabilities (Quarterly): 1.956M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.956M |
| September 30, 2023 | 5.54M |
| June 30, 2023 | 6.277M |
| March 31, 2023 | 19.13M |
| December 31, 2022 | 26.38M |
| September 30, 2022 | 35.23M |
| June 30, 2022 | 33.75M |
| March 31, 2022 | 35.87M |
| December 31, 2021 | 36.81M |
| September 30, 2021 | 45.06M |
| June 30, 2021 | 18.48M |
| March 31, 2021 | 22.83M |
| December 31, 2020 | 22.36M |
| September 30, 2020 | 20.98M |
| June 30, 2020 | 18.26M |
| March 31, 2020 | 17.94M |
| December 31, 2019 | 14.10M |
| September 30, 2019 | 11.82M |
| June 30, 2019 | 11.18M |
| March 31, 2019 | 9.287M |
| December 31, 2018 | 9.487M |
| September 30, 2018 | 62.79M |
| June 30, 2018 | 61.19M |
| March 31, 2018 | 61.57M |
| December 31, 2017 | 58.42M |
| Date | Value |
|---|---|
| September 30, 2017 | 57.29M |
| June 30, 2017 | 56.85M |
| March 31, 2017 | 59.96M |
| December 31, 2016 | 58.32M |
| September 30, 2016 | 59.73M |
| June 30, 2016 | 180.00M |
| March 31, 2016 | 63.87M |
| December 31, 2015 | 66.35M |
| September 30, 2015 | 79.52M |
| June 30, 2015 | 13.60M |
| March 31, 2015 | 11.04M |
| December 31, 2014 | 11.40M |
| September 30, 2014 | 12.63M |
| June 30, 2014 | 17.63M |
| March 31, 2014 | 21.59M |
| December 31, 2013 | 22.37M |
| September 30, 2013 | 25.85M |
| June 30, 2013 | 26.27M |
| March 31, 2013 | 25.45M |
| December 31, 2012 | 34.96M |
| September 30, 2012 | 46.61M |
| June 30, 2012 | 46.74M |
| March 31, 2012 | 43.17M |
| December 31, 2011 | 36.50M |
| September 30, 2011 | 38.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.956M
Minimum
Dec 2023
45.06M
Maximum
Sep 2021
21.26M
Average
19.13M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.263M |
| Shareholders Equity (Quarterly) | 6.307M |
| Current Ratio | 4.223 |
| Net Debt Paydown Yield | 26.70% |